Jonathan Kingslake

CEO, P1vital Products

As the Chief Executive Officer of P1vital Products Ltd, Jonathan has led the company strategy in the development of digital products and services to improve the treatment for mental health conditions to the academic life sciences, pharmaceutical and healthcare industries, utilising his extensive experience of delivering strategic and business value within these sectors. Prior to this, Jonathan was the Chief Operating Officer of P1vital Ltd, responsible for clinical operations and business support functions; and spent 15 years at Merck & Co. in various senior management roles in R&D and manufacturing across Information Technology and business operations. Jonathan has a B.Sc. in Computer Science, from University of Southampton.





Programme sessions

14:30 – 15:30

Digital Health Applications

In this session we will explore the different ways in which digital health technologies have been applied in product development and in the types of applications that are becoming available to patients, clinicians and healthcare providers. A series of leading developers will showcase their innovations to demonstrate the breadth and diversity of opportunity that digital health now offers, highlighting the vibrancy of the digital health sector across the region. Selected innovations span remote monitoring, imaging, digital therapies, mental health applications and autonomous conversation systems.

Location: Snow Room
Chair: Fred Kemp

Showcase Companies:

Better Space – Jim Woods
Brainomix – Konstantinos Dimitriou
IsanSys Healthcare – Keith Errey
My Clinical Outcomes – Tim Williams
Oxehealth – Hugh Lloyd-Jukes
Oxford Brookes – Helen Dawes
P1Vital – Jonathan Kingslake
Ufonia – Nick de Pennington

Digital Health innovation to improve the treatment of depression

Depression is the leading cause of disability in the UK but finding the right treatment that works for patients can be difficult. Optimising the depression pathway by bringing together GPs, healthcare professionals, and charities enabled by our digital solution i-spero will improve the treatment of depression, provide better patient outcomes, decrease costs by reducing GP appointments and referrals to more costly crisis or secondary care, and reduce the societal and economic burden of depression.

Location: Snow Room
Speaker: Jonathan Kingslake

View the full 2018 Programme